The EMPIRICUS trial—the final nail in the coffin of empirical antifungal therapy in the intensive care unit?

Invasive candidiasis (IC) includes primary candidemia, intra-abdominal or deep-seated tissue candidiasis and a combination of both, and is associated with a considerable morbidity and mortality in critically ill patients (1).